Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Nexalin Technology, Inc.
Nexalin Technology, Inc.'s registration statement (File No. 333-298744) was declared effective by the SEC on October 15, 2026. This effectiveness allows the company to proceed with the issuance and sale of the securities detailed in the filing.…more
Nexalin Technology, Inc.
Nexalin Technology has filed an S-1/A registration statement to register the resale of up to 5,752,823 shares of its common stock, pursuant to agreements with Alumni Capital, LP dated August 19, 2026. This offering includes 5.6 million shares under the AMPA, 112,500 commitment shares, and 40,323 shares issuable upon warrant exercise. Additionally, the company completed a 1-for-30 reverse stock split on August 28, 2026, reducing its outstanding shares from approximately 24.88 million to approximately 829,400.…more
Nexalin Technology, Inc.
Nexalin Technology has received formal notification from Nasdaq confirming compliance with the minimum bid price requirement of $1.00 per share. The company must now satisfy the minimum stockholders' equity requirement of $2,500,000 by January 4, 2027, to avoid potential delisting.…more
18 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
Nexalin Technology Regains Nasdaq Minimum Bid Price Compliance
Nexalin Technology has regained compliance with Nasdaq's minimum bid price requirement following a recent reverse stock split. The company must now focus on meeting the minimum stockholders' equity requirement by January 2027 to maintain its listing.…more
●●●●●●●● ●●●●● ●●●●●●
Nexalin Technology shares spiked following a 10-year distribution and manufacturing agreement covering seven South American countries. While the deal expands market reach, investors should note that the partnership lacks specific revenue projections and the stock is experiencing high volatility.…more
●●●●●●●● ●●●●● ●●●●●●
Nexalin Technology has entered into an exclusive 10-year distribution and local manufacturing agreement for its Nexalin Sync device across seven South American countries. This partnership includes an initial 100-unit commercialization program, marking a significant step in the company's transition toward generating commercial revenue.…more
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.